Human Microbiome Based Drugs And Diagnostics Market Size And Share

  • Report Code : TIPRE00016877
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Análisis de la cuota de mercado y oportunidades de los fármacos y diagnósticos basados en el microbioma humano (2025-2031)

Buy Now

Human Microbiome Based Drugs and Diagnostics Market Report Human Microbiome Based Drugs and Diagnostics Market Scope and Analysis Human Microbiome Based Drugs and Diagnostics Market Size and Share

Human Microbiome Based Drugs and Diagnostics Market Report Analysis

Human Microbiome Based Drugs and Diagnostics Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Second Genome Inc
  • Enterome Bioscience
  • Yakult
  • DuPont
  • Vedanta BioSciences
  • Metabiomics Corporation
  • ViThera Pharmaceuticals
  • MicroBiome Therapeutics LLC
  • Merck

Regional Overview

  • América del Norte
  • Europa
  • Asia-Pacífico
  • América del Sur y Central
  • Medio Oriente y África

Market Segmentation

By Producto
  • alimentos
  • probióticos
  • prebióticos
  • alimentos medicinales
  • dispositivos de diagnóstico
  • medicamentos
  • otros suplementos probióticos
By Aplicación
  • Terapéutica
  • Diagnóstico
By Enfermedades
  • diarrea aguda
  • obesidad
  • diabetes
  • trastornos autoinmunes
  • cáncer
  • trastornos mentales
  • otras enfermedades
By Gasto en investigación, tipo de producto
  • instrumentos
  • consumibles